Document:

Second Amended and Restated Consulting Services Agreement

 Exhibit 10.11 
 SECOND AMENDED AND RESTATED 
 CONSULTING SERVICES AGREEMENT 
 THIS SECOND AMENDED AND RESTATED CONSULTING SERVICES AGREEMENT (the “Agreement”), is entered into this [8th] day of March, 2006, by and between DDS Technologies USA, Inc. (“DDS”), a Nevada corporation, with offices at
150 East Palmetto Park Road, Suite 510, Boca Raton, Florida 33432, DDS Holdings, Inc., a Delaware corporation and subsidiary of DDS (“DDS Holdings”), and Lee Rosen, a Florida resident, with an address at 17698 Foxborough
Lane, Boca Raton, Florida 33496 (“Consultant”). 
 WHEREAS, Consultant and DDS Technologies USA, Inc. entered into
that certain Consulting Services Agreement dated March 30, 2004, a copy of which is attached hereto and made a part hereof by reference (the “First Amended and Restated Consulting Services Agreement”); 
 WHEREAS, the parties to this Agreement desire to amend and modify the First Amended and Restated Consulting Agreement consistent with the terms
and conditions set forth herein; 
 WHEREAS, Consultant continues to be experienced in advising companies on capital structure,
mergers and acquisitions and investor relations strategy and has knowledge of and contacts that may further the goals of DDS; 
 WHEREAS, DDS desires to obtain consulting services from Consultant and Consultant desires to continue to provide such services for the fees provided herein; 
 NOW, THEREFORE, in consideration of the mutual promises contained herein, it is agreed by and between DDS, DDS Holdings and Consultant as follows:

 1. Duties of the Consultant. Consultant agrees to use his reasonable best efforts to render assistance to DDS in development
of capital structure, mergers and acquisitions and investor relations strategy (“Consulting Services”). Consultant will provide such services to DDS from time to time only as specifically and reasonably requested by DDS through its
President/Chief Executive Officer to which Consultant will report directly. Consultant will make himself available to DDS, upon reasonable request, including reasonable notice, to perform the Consulting Services for a maximum of ten days per month,
and will perform the Consulting Services with substantially the same diligence exhibited in his performance of the original Consulting Agreement. Consultant hereby acknowledges and agrees that Consultant is not an agent, employee, partner or other
legal representative of DDS with the ability to enter into any agreement on behalf of DDS without the specific prior approval of the President/Chief Executive Officer and Consultant shall not hold himself out as such while providing such consulting
services. Consultant further agrees not to incur or attempt to incur any indebtedness, liability or obligation on behalf of DDS or DDS Holdings or take any action on behalf of DDS or DDS Holdings without the prior approval of the President/Chief
Executive Officer of DDS. 

 2. Term of Agreement. This Agreement shall be for a term of Sixty-One (61) months
effective as of this date, unless earlier terminated in accordance with Section 5 of this Agreement. 
 3. Compensation.
From March 1, 2006 through December 31, 2006, Consultant shall be entitled to: 
 (a) a monthly fee of $7,500 plus during the term
of this Agreement, which fee shall be payable on the 1st of each month. 
 (b) unregistered Company common stock equivalent, to $7,500 at a price of $0.50 per share (15,000 shares) per month. Shares shall have piggyback
registration rights. 
 (c) Company long-term warrants for an additional 15,000 shares of unregistered common stock, per month, at an exercise
price of $0.80 per share and expiring in five years from date of grant. Warrants are issued based on the same terms and conditions as warrants issued under the most recent offering completed January 2006. 
 (d) Company has the option at any time and on any given month to pay a monthly fee of $15,000 per month in full replacement of the above payment plan as
delineated in paragraphs 3(a), 3(b), and 3(c). 
 (e) Consultant shall not be entitled to any reimbursement of expenses incurred as a result
of performing consulting services under this Agreement unless such expenses are reasonable and approved by the President/Chief Executive Officer of DDS prior to Consultant incurring such expenses. 
 4. Renegotiation of Compensation. On or before January 1, 2007, the parties agree to renegotiate and review the Compensation of
Consultant for possible reinstatement of the prior total compensation fee of $15,000 per month so long as the Company has sufficient positive cash flow to sustain these monthly payments in the future. In the event the Company does not have
sufficient positive cash flow to renegotiate Consultant’s Compensation, the compensation to consultant as provided in Paragraph 3 shall continue in full force and effect until the Company has sufficient positive cash flow to pay Consultant a
$15,000 cash payment or until renegotiated by the parties. 

 5. Independent Contractor. This Agreement is not an employment contract and does not give
Consultant any employment rights. Both Consultant and DDS agree that the relationship created by this Agreement is that of an independent contractor and not that of employee and employer. Consultant hereby acknowledges that Consultant shall not at
any time during the term of this Agreement unilaterally act on behalf of DDS or DDS Holdings unless and until Consultant seeks and obtains specific prior approval from the President/Chief Executive Officer of DDS. The Consultant is responsible for
the payment of any taxes, including without limitation, all Federal, State and local personal and business income taxes, sales and use taxes, other business taxes and license fees arising out of the activities of the Consultant. 
 6. Termination. This Agreement may be terminated by DDS only for cause (as defined below) effective immediately upon the giving by DDS to
Consultant of written notice of the termination for cause, which notice shall specify the basis for such termination. Upon termination of this Agreement in accordance with this Section 5, Consultant shall not be entitled to receive any further
fees hereunder except such fees as shall be payable through the date of such termination. For purposes of this Agreement, the term “cause” shall mean: 
 (a) the Consultant breaches the provisions of the third sentence of Section 4 above limiting Consultant’s authority to act on behalf of DDS or DDS Holdings which breach is not cured within fifteen days after
receipt by the Consultant of written notice of the same; 
 (b) the Consultant is convicted of a felony, provided that such conviction is not
overturned on appeal and any appeal period has expired; 
 (c) the Consultant willfully damages property of DDS or DDS Holdings; 

(d) any act by the Consultant during the term of this Agreement involving theft, dishonesty, fraud or embezzlement against DDS or DDS Holdings
resulting in material harm to DDS and DDS Holdings which act is not cured within fifteen days after receipt by the Consultant of written notice of same; 
 (e) the Consultant not making himself available to DDS, upon reasonable notice of request by DDS, to perform the Consulting Services for up to ten days per month in accordance with Section 1 of this Agreement;

 (f) the Consultant not performing such Consulting Services as specifically and reasonably requested by DDS through its President/Chief
Executive Officer in accordance with Section 1 of this Agreement; 

 (g) the Consultant not performing the Consulting Services in a manner and dedication as exhibited when
Consultant performed similar duties in connection with the Original Consulting Agreement; or 
 (h) the Consultant breaches Section 6 of
this Agreement regarding disclosure of Confidential Information which breach is not cured within fifteen days after receipt by Consultant of written notice of same. 
 The Consultant shall be given written notice by DDS that it intends to terminate this Agreement for cause, which written notice shall specify the act or acts upon the basis of which DDS intends to terminate this
Agreement, and the Consultant shall then be given the opportunity, within fifteen days of his receipt of such notice, to have a meeting with the Board of Directors of DDS to discuss such act or acts. The Consultant shall be given fifteen days after
such meeting within which to cease or correct the performance (or nonperformance) giving rise to such written notice. 
 It is specifically
understood and agreed that unsatisfactory performance by Consultant of Consulting Services beyond the grounds specifically enumerated in this Section 5 shall not constitute grounds for termination of this Agreement. 
 7. Confidential Information. Consultant hereby acknowledges that during the performance of this Agreement, Consultant may learn or receive
information related to the business of DDS or DDS Holdings, including, but not limited to, names of its investors or prospective investors, its manner of operations, its business plan, its marketing, its methods, its vendors and its suppliers
(“Confidential Information”). Consultant hereby confirms that it will not divulge or disclose Confidential Information to any other person, other than in connection with the performance of the Consulting Services, except as may be required
by law. 
 8. Original Consulting Agreement. The parties agree that the Original Consulting Agreement shall be null and void
and of no further force or effect. Consultant hereby releases DDS from any and all obligations arising out of the Original Consulting Agreement. Each of DDS and DDS Holdings hereby releases Consultant from any and all obligations arising out of the
Original Consulting Agreement. 
 9. Notices. Each notice required to be given pursuant to this Agreement shall be properly
given if sent by one party to the other by certified or registered mail, postage prepaid, or registered return receipt courier mail addressed to the other at the address set forth in the first paragraph of this Agreement. 
 10. Non-waiver. The failure of either party to exercise any of its rights under this Agreement at any time does not constitute a breach
thereof and shall not be deemed to be a waiver of such rights or a waiver of any subsequent breach. 

 11. Choice of Law. This Agreement and the respective rights and obligations of the parties
shall be governed by and determined in accordance with the laws of the State of Florida, without regard to its conflict of law provision. 
 12. Authority. Each party represents that the individual signing this Agreement on that party’s behalf has been duly authorized to bind said party to undertake the obligations and to carry out the terms and provisions
thereof. 
 13. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be
effective and valid under applicable law. If any court of competent jurisdiction determines that any part of this Agreement is invalid or unenforceable, that determination shall not impair or nullify the remainder of the Agreement. 
 14. Headings. The headings in this Agreement are inserted for convenience only and are not to be considered in construction of the
provisions hereof. 
 15. Miscellaneous. This Agreement (a) may only be amended by a writing signed by DDS and Consultant,
(b) inures to the benefit of and is binding upon DDS and Consultant and each of their successors and assigns, except that Consultant may not assign any of Consultant’s rights or obligations under this Agreement without first obtaining the
written consent of DDS, (c) constitutes the entire agreement between DDS and Consultant with respect to the subject matter of this Agreement, superseding all oral and written proposals, representations, understandings and agreements previously
made or existing with respect to such subject matter, and (d) may be executed in counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument. 
 IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the effective date in the introduction paragraph hereof.

  

			
	DDS TECHNOLOGIES USA, INC.
		
	By:	 	 /s/ S. L. Sterling

	Name:	 	Spencer Sterling
	Title:	 	President/Chief Executive Officer
	
	DDS HOLDINGS, INC.
		
	By:	 	 /s/ Joseph N. Fasciglione

	Name:	 	 Joseph N. Fasciglione

	Title:	 	 Chief Financial Officer
  

	
	 /s/ Lee Rosen

	Lee Rosen

 EXHIBIT “A” 
 The First Amended and Restated Consulting Services Agreement 
 The Original
Consulting AgreementStock Option Plan

 Exhibit 10.24 
 DDS TECHNOLOGIES USA, INC. 
 STOCK OPTION PLAN 
 SECTION 1. PURPOSE 
 The purpose of the Stock Option
Plan (the “Plan”) of DDS Technologies USA, Inc., a Nevada corporation (the “Company”), is to enable the Company to attract, retain and motivate key employees responsible for the success and growth of the Company and its
subsidiaries by offering selected officers and other key employees, directors and advisors of the Company and its Subsidiaries an opportunity to purchase Shares of Company Stock. The Plan provides for the grant of Options to purchase Shares. Options
granted under the Plan may include NQSOs, as well as ISOs intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). 
 Certain capitalized terms used in this Plan are defined in Section 2. 
 SECTION 2. DEFINITIONS 
 a. “Board” means the Board of Directors of the Company. 

b. “Cause” has the meaning ascribed to the term in an Optionee’s Employment Agreement, if any exists. In the absence of an applicable
Employment Agreement, “Cause” means (i) the unauthorized use or disclosure of the confidential information or trade secrets of the Company, (ii) conviction of, or a plea of “guilty” or “no contest” to, a
felony under the laws of the United States or any state, (iii) negligence or misconduct in the performance of Optionee’ s duties or (iv) material breach of the Optionee’s obligations under any agreement or arrangement with the
Company, a Subsidiary or any affiliate thereof. 
 c. “Change In Control” means: 
 i. the sale, exchange, transfer or other disposition of 50% or more in value of the assets of the Company to another Person or entity, except to an
entity controlled directly or indirectly by the Company; or 
 ii. the merger, consolidation or other reorganization of the Company in which
the Company is not the surviving entity and in which the hertoric shareholders of the Company continue to own less than 50% of the outstanding securities of the acquiror immediately following the transaction, or a plan of liquidation or dissolution
of the Company other than pursuant to bankruptcy or insolvency laws is adopted. 
 Notwithstanding the foregoing, a Change in Control will not be deemed to
have occurred for purposes of this Plan (1) in the event of a sale, exchange, transfer or other disposition of substantially all of the assets of the Company to, or a merger, consolidation or other reorganization involving the Company and the
Optionee, alone or with other officers of the Company, or any entity in which the Optionee (alone or with other officers) has, directly or indirectly, at least a 25% equity or ownership interest; or (2) in a transaction otherwise commonly
referred to as a “management leveraged buy-out.” 

 d. “Committee” means a committee of the Board, as described in Section 3(a). 

e. “Consultant” means a person who performs bona fide services for the Company or a Subsidiary as a consultant or advisor, excluding
Employees and Directors. 
 f. “Director” means a member of the Board. 
 g. “Disability” has the meaning ascribed to the term in an Optionee’s Employment Agreement, if any exists. In the absence of an applicable
Employment Agreement, “Disability” means a permanent disability within the meaning of Section 22(e)(3) of the Code. 
 h.
“Employee” means any individual who is a common-law employee of the Company or a Subsidiary. 
 i. “Employment Agreement”
means, for any Optionee, an employment agreement between the Optionee and the Company or any Subsidiary in effect at the time of the grant of an Option under the Plan. 
 j. “Exercise Price” means the amount for which one Share may be purchased when an Option is exercised, as specified by the Board in the applicable Stock Option Agreement. 
 k. “Fair Market Value,” as of a particular date, means: 
 i. if the Shares are then listed or admitted to trading on a national securities exchange or reported on NASDAQ, the closing price of a Share on the exchange or on NASDAQ as of the last trading day on which the Shares
were sold or reported prior to the date of determination; or 
 ii. if the Shares are not then listed or admitted to trading on a national
securities exchange or reported on NASDAQ, such value as the Board, acting in good faith and in its sole discretion, determines. 
 l.
“ISO” means an employee incentive stock option described in Section 422(b) of the Code. 
 m. “NQSO” means a stock
option not described in Section 422(b) of the Code. 
 n. “Option” means an ISO or NQSO granted under the Plan that entitles
the holder to purchase Shares. 
 o. “Optionee” means a person who holds an Option. 
  

 2 

 p. “Person” means any individual, corporation (including any non-profit corporation), general
or limited partnership, limited liability company, joint venture, estate, trust, association, organization, or governmental body. 
 q.
“Service” means service as an Employee, Consultant or Director. 
 r. “Share” means one share of Stock issuable when an
Option is exercised, as adjusted in accordance with Section 8 (if applicable). 
 s. “Stock” means the Common Stock of the
Company. 
 t. “Stock Option Agreement” means the agreement or other instrument between the Company and an Optionee that evidences
and sets forth the terms, conditions and restrictions pertaining to Optionee’s Option. 
 u. “Subsidiary” means any
corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns shares possessing 50% or more of the total combined voting
power of all classes of shares in one of the other corporations in the chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan will be considered a Subsidiary commencing as of that date. 
 SECTION 3. ADMINISTRATION 
 a. Committees of the
Board. The Plan may be administered by one or more Committees. A Committee will consist of one or more members of the Board, and will have the authority and be responsible for those functions assigned to it by the Board. If no Committee is
appointed, the entire Board will administer the Plan. Any reference to the Board in the Plan will be construed as a reference to the Committee, if any, to which the Board assigns a particular function in connection with the Plan. 
 b. Powers of the Board . Subject to the provisions of the Plan, the Board has the power to: 
 i. Determine and designate those individuals selected to receive Options, the time at which each Option will be granted, and the number of Shares subject
to each Option; 
 ii. Determine the time and manner of exercise, the duration of the exercise periods, and the Exercise Price of the
Options granted; 
 iii. Prescribe, amend, or rescind any rules and regulations necessary or appropriate for the administration of the Plan;

 iv. Correct any defect, supply any deficiency, and reconcile any inconsistency in the Plan or in any related Option or agreement; and

  

 3 

 v. Make other determinations and take such other action in connection with the administration of the
Plan as it deems necessary or advisable. 
 c. Delegation of Duties. The Board may direct appropriate officers of the Company to
implement its rules, regulations and determinations and to execute and deliver on behalf of the Company such documents, forms, agreements and other instruments as are deemed by the Board to be necessary for the administration and implementation of
the Plan. 
 d. Interpretation of Plan. The Board has the power to interpret and construe the Plan and all related Options and
agreements. All decisions, interpretations and determinations of the Board with respect to the Plan will be final and binding on all Optionees and all persons deriving their rights from Optionees. 
 e. Indemnification. Each member of the Board is indemnified and held harmless by the Company against any cost or expense (including any sum paid
in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the Plan to the extent permitted by applicable law. This indemnification is in addition to any rights of indemnification a member
may have as a Director or otherwise under the by-laws of the Company or a Subsidiary, any agreement, any vote of shareholders or disinterested directors, or otherwise. 
 SECTION 4. ELIGIBILITY 
 a. General Rule. NQSOs may be granted to Employees, Consultants and
Directors. Only Employees are eligible to receive ISOs. 
 b. Ten-Percent Shareholders. An individual who owns more than 10% of the
total combined voting power of all classes of outstanding shares of the Company or any of its Subsidiaries (as determined in accordance with Section 424(d) of the Code) will not be eligible for the grant of an ISO unless (i) the Exercise
Price is at least 110% of the Fair Market Value of a Share on the date of grant and (ii) the Option by its terms is not exercisable after the expiration of 5 years from the date of grant. 
 SECTION 5. STOCK SUBJECT TO PLAN 
 a. Basic
Limitation. The aggregate number of Shares that may be issued under the Plan on exercise of Options must not exceed 3,000,000 Shares, subject to adjustment pursuant to Section 8. Shares offered under the Plan may be authorized but unissued
Shares or treasury Shares. The number of Shares that are subject to Options outstanding at any time under the Plan must not exceed the number of Shares that then remain available for issuance under the Plan. The Company, during the term of the Plan,
at all times will reserve and keep available sufficient Shares to satisfy the requirements of the Plan. 
 b. Additional Shares. In
the event that any outstanding Option for any reason expires or is canceled or otherwise terminates, the Shares allocable to the unexercised portion of that Option again will be available for purposes of the Plan. If Shares issued under the Plan are
reacquired by the Company, those Shares again will be available for purposes of the Plan. 
  

 4 

 SECTION 6. TERMS AND CONDITIONS OF OPTIONS 
 a. Stock Option Agreement. Each grant of an Option under the Plan will be evidenced by a Stock Option Agreement between the Optionee and the
Company. The Option will be subject to terms and conditions that are consistent with the Plan and that the Board deems appropriate for inclusion in a Stock Option Agreement. The provisions of Stock Option Agreements entered into under the Plan need
not be identical. 
 b. Number of Shares. Each Stock Option Agreement will specify the number of Shares that are subject to the Option
and will provide for the adjustment of that number in accordance with Section 8. The Stock Option Agreement also will specify whether the Option is an ISO or NQSO. However, if any portion of an Option does not meet the requirements to qualify
as an ISO, that portion will be an NQSO. 
 c. Exercise Price. Each Stock Option Agreement will specify the Exercise Price. The
Exercise Price under any Option will be determined by the Board in its sole discretion, except that the Exercise Price of ISOs may not be less than 100% of the Fair Market Value of a Share on the date of grant, and any higher percentage required by
Section 4(b). 
 d. Limitation on Amount. To the extent that the aggregate Fair Market Value (determined with respect to each ISO
as of the time the ISO is granted) of the Shares with respect to which ISOs are exercisable for the first time by an Optionee during any calendar year (under all Plans of the Company and its Subsidiaries) exceeds $100,000, the option or portions of
the option that exceed the limit (according to the order in which they were granted) will be treated as NQSOs. No individual Optionee may receive an Option grant for more than 1,000,000 Shares in any calendar year. 
 e. Withholding Taxes. As a condition to the exercise of an Option, the Optionee will make such arrangements as the Board may require for the
satisfaction of any federal, state, local or foreign withholding tax obligations that may arise in connection with the exercise. The Optionee also will make such arrangements as the Board of Directors may require for the satisfaction of any
withholding tax obligations that may arise in connection with the disposition of Shares acquired by exercising an Option. 
 f.
Exercisability. Each Stock Option Agreement will specify when all or any installment of the Option becomes exercisable. The exercisability provisions of any Stock Option Agreement will be determined by the Board in its sole discretion.
Exercisability may be based on performance criteria. 
 g. Accelerated Exercisability. Unless the applicable Stock Option Agreement
provides otherwise, if the Company is subject to a Change in Control before the Optionee’s Service terminates, all of an Optionee’s Options will become exercisable in full, subject to such terms and conditions as the Board, in its sole
discretion, deems appropriate. 
  

 5 

 h. Basic Term. The Stock Option Agreement will specify the term of the Option. The Board in its
sole discretion may determine when an Option is to expire, except that the term may not exceed 10 years from the date of grant, and any shorter term required by Section 4(b). 
 i. Nontransferability. No Option may be transferred by the Optionee other than by beneficiary designation, will or the laws of descent and
distribution, except as may otherwise be determined by the Board with respect to NQSOs only. An Option may be exercised during the lifetime of the Optionee only by the Optionee or, with respect to NQSOs only, by the Optionee’s guardian or legal
representative, by any permitted transferee of the Optionee or by that permitted transferee’s guardian or legal representative. No Option or interest in it may be pledged or hypothecated by the Optionee during the Optionee’s lifetime,
whether by operation of law or otherwise, or be made subject to execution, attachment or similar process. 
 j. Termination of Service
(Except by Death). Unless otherwise provided in an Optionee’s Stock Option Agreement, if an Optionee’s Service terminates for any reason other than the Optionee’s death, then the Optionee’s Options will expire on the earliest
of the following: 
 i. The expiration date determined pursuant to subsection (h) above; 
 ii. The date 90 days after the date of the termination of the Optionee’s Service for any reason other than Cause or Disability, or a later date as
the Board may determine; 
 iii. The date of the termination of the Optionee’s Service for Cause, or a later date as the Board may
determine; or 
 iv. The date 12 months after the termination of the Optionee’s Service by reason of an Optionee’s Disability.

 The Optionee may exercise all or part of his or her Options at any time before the expiration of the Options under this subsection, but only to the extent
that the Options had become exercisable before the date the Optionee’s Service terminated (or became exercisable as a result of the termination). The balance of the Options will lapse when the Optionee’s Service terminates. If the Optionee
dies after the termination of his or her Service but before the expiration of the Optionee’s Options, all or part of the Options may be exercised (prior to expiration) by the executors or administrators of the Optionee’s estate or by any
person who has acquired the Options directly from the Optionee by beneficiary designation, bequest or inheritance, or in the case of NQSOs only, by other transfer, if permitted, but in any event only to the extent that the Options had become
exercisable before the Optionee’s Service terminated (or became exercisable as a result of the termination). For purposes of this subsection (j), date of termination means the date the Optionee is given notice of termination by the Company.

 k. Leaves of Absence. For purposes of subsection (j) above, Service will be deemed to continue while the Optionee is on a bona
fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of Service for this purpose is expressly required by the terms of the leave or by applicable law (as determined by the Company). 
  

 6 

 l. Death of Optionee. If an Optionee dies while in Service, then his or her Options expire on the
earlier of the following dates: 
 i. The expiration date determined pursuant to subsection (h) above; or 
 ii. The date 12 months after the Optionee’s death. 
 At any time before the expiration of the Options under the preceding sentence, all or part of the Optionee’s Options may be exercised by the executors or administrators of the Optionee’s estate or by any person who has acquired
the Options directly from the Optionee by beneficiary designation, bequest or inheritance, or in the case of NQSOs only, by other transfer, if permitted, but in any event only to the extent that the Options had become exercisable before the
Optionee’s death or became exercisable as a result of death. The balance of the Options will lapse when the Optionee dies. 
 m. No
Rights as a Shareholder. An Optionee, or a transferee of an Optionee, has no rights as a shareholder with respect to any Shares covered by an Option prior to the date of issuance to the Optionee or transferee of a certificate or certificates for
the Shares. 
 n. Modification, Extension and Assumption of Options. Within the limitations of the Plan, the Board may modify or
extend outstanding Options. However, without the consent of the Optionee, no modification may impair the Optionee’s rights or increase the Optionee’s obligations under the Option. 
 o. Restrictions on Transfer of Shares. Any Shares issued on exercise of an Option will be subject to such special forfeiture conditions, rights of
repurchase, rights of first refusal and other transfer restrictions as the Board may determine. These restrictions will be set forth in the applicable Stock Option Agreement and will apply in addition to any restrictions that may apply to holders of
Shares generally. The Company will be under no obligation to sell or deliver Shares on exercise of Options under the Plan unless the Optionee executes an agreement giving effect to the restrictions in the form prescribed by the Company. 

p. Additional Grants. If otherwise eligible, an Optionee may be granted an additional Option or Options under this Plan or any other share
option or purchase plan of the Company. 
 q. Cancellation and New Options. The Board has the authority to grant to the holder of an
outstanding Option, in exchange for the surrender and cancellation of that Option, a new Option having a purchase price lower than provided in the Option surrendered and canceled and containing other terms and conditions as the Board may prescribe
in accordance with the provisions of the Plan. 
  

 7 

 r. Buyout Provisions. The Board may at any time offer to buy out for a payment in cash or Shares,
an Option previously granted, based on such terms and conditions as the Board establishes and communicates to the Optionee at the time that the offer is made. 
 SECTION 7. PAYMENT FOR SHARES 
 a. General Rule. The entire Exercise Price of Shares issued under the Plan is payable
in cash or cash equivalents when the Shares are purchased. 
 b. Surrender of Stock. To the extent a Stock Option Agreement so
provides, all or any part of the Exercise Price may be paid by surrendering, or attesting to the ownership of, Shares that are already owned by the Optionee. These Shares will be surrendered to the Company in good form for transfer and will be
valued at their Fair Market Value on the date when the Option is exercised. Unless the Board of Directors otherwise determines, the Optionee will not surrender, or attest to the ownership of, Shares in payment of the Exercise Price if that action
would cause the Company to recognize compensation expense (or additional compensation expense) with respect to the Option for financial reporting purposes. 
 c. Promissory Note. To the extent that a Stock Option Agreement so provides, all or a portion of the Exercise Price of Shares issued under the Plan may be paid with a full-recourse promissory note. The Shares
will be pledged as a security for payment of the principal amount of the promissory note and interest on it. The interest rate payable under the terms of the promissory note will not be less than the minimum rate (if any) required to avoid the
imputation of additional interest under the Code. Subject to the foregoing, the Board of Directors (at its sole discretion) will specify the term, interest rate, amortization requirements (if any) and other provisions of the note. 
 d. Exercise/Sale. To the extent that a Stock Option Agreement so provides, and if the Stock is publicly traded, payment may be made all or in part
by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell the Shares and to deliver all or part of the sales proceeds to the Company in payment of all or part of the
Exercise Price and any withholding taxes. 
 e. Exercise/Pledge. To the extent that a Stock Option Agreement so provides, and if the
Stock is publicly traded, payment may be made all or in part by the delivery (on a form prescribed by the Company) of an irrevocable direction to pledge the Shares to a securities broker or lender approved by the Company, as security for a loan, and
to deliver all or part of the loan proceeds to the Company in payment of all or part of the Exercise Price and any withholding taxes. 
 SECTION 8.
ADJUSTMENT OF SHARES 
 a. General. If the outstanding shares of Stock of the Company are increased, decreased, changed into or
exchanged for a different number or kind of shares or securities of the Company through a reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar transaction, the Board may make such
appropriate and 
  

 8 

 proportionate adjustments as it deems necessary or appropriate in one or more of (i) the number of Shares specified
in Section 5, (ii) the number of Shares covered by each outstanding Option and (iii) the Exercise Price under each outstanding Option. 
 b. Mergers and Consolidations. In the event that the Company is a party to a merger, consolidation or other reorganization, the Board may provide that outstanding Options will be subject to the agreement of
merger, consolidation or other reorganization, which agreement, without the Optionees’ consent, may provide for the cancellation of each outstanding Option after payment to the Optionee of an amount in cash or cash equivalents equal to
(i) the Fair Market Value of the Shares subject to the Option at the time of the merger, consolidation or other reorganization minus (ii) the Exercise Price of the Shares subject to the Option. 
 c. Reservation of Rights. Except as provided in this Section, an Optionee has no rights by reason of (i) any subdivision or consolidation of
shares of any class, (ii) the payment of any dividend or (iii) any other increase or decrease in the number of shares of any class. Any issuance by the Company of shares of Stock of any class, or securities convertible into shares of Stock
of any class, will not affect the number or Exercise Price of Shares subject to an Option. The grant of an Option pursuant to the Plan will not affect in any way the right or power of the Company to make adjustments, reclassifications,
reorganizations or changes of its capital or business structure, to merge or consolidate or to dissolve, liquidate, sell or transfer all or any part of its business or assets. 
 SECTION 9. CONDITIONS UPON ISSUANCE OF SHARES 
 a. Securities Law Requirements. Shares may not
be issued under the Plan unless the issuance and delivery of these Shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations
promulgated under it, state and federal securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities then may be traded. 
 b. Investment Representations. As a condition to the exercise of an Option, the Board may require the person exercising the Option to represent
and warrant at the time of exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute the Shares if, in the opinion of counsel for the Company, such a representation is required.

 c. Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction,
which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares under this Plan, will relieve the Company of any liability in respect of the failure to issue or sell those Shares as to which the
requisite authority has not been obtained. 
  

 9 

 SECTION 10. NO RETENTION RIGHTS 
 Nothing in the Plan or in any Option granted under the Plan will confer on the Optionee any right to continue in Service for any period of time or will interfere with or otherwise restrict in any way the rights of the
Company (or any Subsidiary) or of the Optionee, which rights are expressly reserved by each, to terminate his or her Service at any time and for any reason. 
 SECTION 11. DURATION AND AMENDMENTS 
 a. Term of the Plan. Subject to the approval of the Company’s shareholders,
the Plan is effective on the date of its adoption by the Board. If the shareholders fail to approve the Plan, any grants of Options that already have occurred will be rescinded, and no additional grants will be made. The Plan will terminate
automatically 10 years after its adoption by the Board, and may be terminated on any earlier date pursuant to subsection (b) below. 
 b. Right to Amend or Terminate the Plan. The Board may amend, suspend or terminate the Plan at any time and for any reason. However, any amendment of the Plan that increases the number of Shares available for issuance under the Plan
(except as provided in Section 8), or that materially changes the class of persons who are eligible for the grant of Options, is subject to the approval of the Company’s shareholders. Shareholder approval will not be required for any other
amendment of the Plan. 
 c. Effect of Amendment or Termination. No Shares will be issued or sold under the Plan after its
termination, except on exercise of an Option granted prior to the termination. No amendment, suspension, or termination of the Plan will, without the consent of the holder, alter or impair any rights or obligations under any Option previously
granted under the Plan. 
 SECTION 12. APPLICABLE LAW 
 The Plan and all Options granted under it will be construed and interpreted in accordance with, and governed by, the laws of the State of Nevada, other than its laws regarding choice of law. 
  

 10 

 SECTION 13. EXECUTION 
 To record the adoption of the Plan by the Board, the Company has caused its authorized officer to execute it as of, April 12, 2006, the date of such adoption by the Board. 
  

			
	DDS TECHNOLOGIES USA, INC.
		
	By:	 	 /s/ Spencer L. Sterling

		
	Title:	 	 President and Chief Executive Officer

  

 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]